Last reviewed · How we verify

NCT06071546

Clinical Investigation of a New Version of MAIA Microperimeter on Healthy Subjects and Patients With Retinal Pathology

Completed NA Last updated 13 August 2024
What this trial tests

NA trial testing MAIA in Healthy Eyes in 68 participants. Completed in 12 July 2024.

Timeline
17 October 2023
Primary endpoint
12 July 2024
12 July 2024

Quick facts

Lead sponsorCentervue SpA
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposeother
Enrollment68
Start date17 October 2023
Primary completion12 July 2024
Estimated completion12 July 2024
Sites1 location across Switzerland

Drugs / interventions tested

Conditions studied

Sponsor

Centervue SpA

Who can join

Adults 18 to 90, any sex, with Healthy Eyes or Retinal Diseases. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this pre-market, monocentric cross-sectional study is to evaluate the clinical usefulness of a new version of the MAIA device (MAIA) through an agreement with the established version of the MAIA microperimeter (MAIA 2013 EDITION). Moreover, the study aims to evaluate MAIA test-retest repeatability in comparison with MAIA 2013 EDITION and to evaluate MAIA safety and adverse events. These purposes will be achieved by collecting data of healthy subjects and patients with retinal pathology. All participants will undergo repeated microperimetric examinations with both devices during one single visit.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Validation and Repeatability of Differential Light Sensitivity Measurements with the Novel MAIA Microperimetry Device.
    Ansari G, Giudici NL, Cancian G, Rossouw P, et al · · 2025 · cited 1× · PMID 40980023 · DOI 10.1016/j.xops.2025.100886

Verify or expand the search:

Other trials of MAIA

Trials testing the same drug.

Other recruiting trials for Healthy Eyes

Currently open trials in the same condition.

Other Centervue SpA trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06071546.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing